Southport Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $214K | Sell |
1,320
-1,513
| -53% | -$220K | 0.08% | 207 |
|
|
2021
Q4 | $384K | Buy |
2,833
+302
| +12% | +$35.7K | 0.07% | 218 |
|
|
2021
Q3 | $273K | Sell |
2,531
-11,566
| -82% | -$1.32M | 0.11% | 190 |
|
|
2021
Q2 | $1.59M | Buy |
14,097
+293
| +2% | +$33K | 0.39% | 79 |
|
|
2021
Q1 | $1.49M | Buy |
13,804
+161
| +1% | +$17.2K | 0.39% | 79 |
|
|
2020
Q4 | $1.46M | Buy |
13,643
+11
| +0.1% | +$1.06K | 0.52% | 59 |
|
|
2020
Q3 | $1.19M | Sell |
13,632
-344
| -2% | -$32.4K | 0.46% | 63 |
|
|
2020
Q2 | $1.37M | Buy |
13,976
+2,028
| +17% | +$179K | 0.59% | 56 |
|
|
2020
Q1 | $910K | Buy |
11,948
+96
| +0.8% | +$8.18K | 0.48% | 70 |
|
|
2019
Q4 | $1.05M | Buy |
11,852
+395
| +3% | +$32.8K | 0.41% | 80 |
|
|
2019
Q3 | $867K | Buy |
11,457
+786
| +7% | +$53.9K | 0.39% | 82 |
|
|
2019
Q2 | $776K | Buy |
10,671
+4
| +0% | +$314 | 0.35% | 85 |
|
|
2019
Q1 | $860K | Buy |
10,667
+974
| +10% | +$79.7K | 0.38% | 83 |
|
|
2018
Q4 | $894K | Buy |
9,693
+106
| +1% | +$9.32K | 0.45% | 74 |
|
|
2018
Q3 | $907K | Buy |
9,587
+3
| +0% | +$284 | 0.38% | 76 |
|
|
2018
Q2 | $888K | Sell |
9,584
-7,460
| -44% | -$729K | 0.4% | 73 |
|
|
2018
Q1 | $1.61M | Sell |
17,044
-811
| -5% | -$89.1K | 0.72% | 45 |
|
|
2017
Q4 | $1.73M | Buy |
17,855
+4,859
| +37% | +$458K | 0.66% | 50 |
|
|
2017
Q3 | $1.16M | Sell |
12,996
-53
| -0.4% | -$4.04K | 0.49% | 72 |
|
|
2017
Q2 | $946K | Buy |
13,049
+169
| +1% | +$11.4K | 0.42% | 82 |
|
|
2017
Q1 | $839K | Sell |
12,880
-997
| -7% | -$62.7K | 0.47% | 71 |
|
|
2016
Q4 | $869K | Buy |
13,877
+66
| +0.5% | +$4.03K | 0.53% | 65 |
|
|
2016
Q3 | $871K | Sell |
13,811
-672
| -5% | -$43.5K | 0.61% | 59 |
|
|
2016
Q2 | $897K | Sell |
14,483
-300
| -2% | -$18.3K | 0.5% | 60 |
|
|
2016
Q1 | $844K | Sell |
14,783
-662
| -4% | -$36.9K | 0.54% | 65 |
|
|
2015
Q4 | $915K | Hold |
15,445
| – | – | 0.59% | 58 |
|
|
2015
Q3 | $840K | Sell |
15,445
-100
| -0.6% | -$6.51K | 0.56% | 59 |
|
|
2015
Q2 | $1.04M | Sell |
15,545
-2,735
| -15% | -$179K | 0.63% | 53 |
|
|
2015
Q1 | $1.07M | Buy |
18,280
+2,635
| +17% | +$159K | 0.63% | 55 |
|
|
2014
Q4 | $1.02M | Hold |
15,645
| – | – | 0.61% | 56 |
|
|
2014
Q3 | $904K | Buy |
15,645
+845
| +6% | +$46.9K | 0.6% | 56 |
|
|
2014
Q2 | $835K | Sell |
14,800
-1,075
| -7% | -$56.4K | 0.56% | 56 |
|
|
2014
Q1 | $816K | Sell |
15,875
-900
| -5% | -$45.5K | 0.57% | 55 |
|
|
2013
Q4 | $886K | Sell |
16,775
-6,500
| -28% | -$319K | 0.62% | 54 |
|
|
2013
Q3 | $1.04M | Buy |
23,275
+6,632
| +40% | +$294K | 0.81% | 43 |
|
|
2013
Q2 | $688K | Buy |
+16,643
| New | +$728K | 0.56% | 58 |
|
Other funds holding ABBV
Southport Capital Management's ABBV Position: Q1 2022 in Review
Southport Capital Management reduced its AbbVie (ABBV) stake by 53% in Q1 2022, selling an estimated $220K and leaving 1,320 shares worth $214K. The position accounts for 0.08% of the portfolio, ranked #207.
Southport Capital Management first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.73M in Q4 2017. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- Southport Capital Management held 1,320 shares of AbbVie worth $214K as of Q1 2022.
- Southport Capital Management sold 1,513 AbbVie shares in Q1 2022, an estimated $220K.
- AbbVie made up 0.08% of Southport Capital Management's portfolio in Q1 2022, its #207 holding.
- Southport Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- Southport Capital Management's AbbVie position peaked at $1.73M in Q4 2017.
- 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.